Latest news with #OrthoPediatrics
Yahoo
a day ago
- Business
- Yahoo
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025
OrthoPediatrics Corp. WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ('OrthoPediatrics' or the 'Company') (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2025 financial results on August 5, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 5, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event. About OrthoPediatrics Corp. Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics' global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit Investor Contact Philip Trip Taylor Gilmartin Group philip@ 415-937-5406
Yahoo
16-07-2025
- Health
- Yahoo
Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics® Products
WARSAW, Ind., July 16, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ('OrthoPediatrics' or the 'Company') (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced a significant milestone in the ongoing Global POISE (Pediatric Orthopedic Implant Safety and Efficacy) Study: more than 600 implants are now being observed across 300+ pediatric patients as part of this study. Global POISE is a multi-center, post-market, prospective clinical follow-up study, designed to assess the safety and efficacy of a range of OrthoPediatrics' implant devices. This international study is focused on verifying implant survival and identifying any device-related adverse events. Launched in 2023, Global POISE now includes 13 active sites and growing, with data currently being collected from Canada, the United States, Australia, New Zealand and South Africa. The insights generated from this study will inform further refinement of OrthoPediatrics devices to meet the specific needs of growing children with orthopedic conditions. The sites involved in Global POISE are committed to broadening the study's reach and continue to enroll additional patients across 17 different implant types to further enhance the understanding of their safety and long-term effectiveness. OrthoPediatrics' Sr VP of Quality, Clinical and Regulatory Affairs, Ray Garrison, commented, 'We are thrilled to see the Global POISE Study reach this significant milestone. This achievement is a testament to the dedication and collaboration of OrthoPediatrics and the research team at BC Children's Hospital. As the study continues to expand, we are excited about the valuable insights it will generate that will ultimately improve the outcomes for children undergoing orthopedic procedures around the world. OrthoPediatrics remains committed to advancing pediatric orthopedic care through innovative solutions designed to meet the unique needs of young patients.' For more information about the Global POISE study, please visit and About BC Children's Hospital BC Children's Hospital is a pediatric teaching and research hospital in Vancouver, British Columbia. It provides world-leading care for its patients and is recognized for its innovative research in child health. The Global POISE study is spearheaded by principal investigators Dr. Anthony Cooper and Dr. Kishore Mulpuri, two orthopedic surgeons of BC Children's Hospital. About OrthoPediatrics Corp. Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics' global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit Investor ContactPhilip Trip TaylorGilmartin Groupphilip@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10-05-2025
- Business
- Yahoo
OrthoPediatrics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Revenue: US$52.4m (up 17% from 1Q 2024). Net loss: US$10.7m (loss widened by 37% from 1Q 2024). US$0.46 loss per share (further deteriorated from US$0.34 loss in 1Q 2024). Our free stock report includes 2 warning signs investors should be aware of before investing in OrthoPediatrics. Read for free now. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates by 2.2%. Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are up 3.0% from a week ago. Before we wrap up, we've discovered 2 warning signs for OrthoPediatrics that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25-03-2025
- Business
- Yahoo
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
WARSAW, Ind., March 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ('OrthoPediatrics' or the 'Company') (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference. Event: 24th Annual Needham Virtual Healthcare Conference Format: Fireside Chat Date: Tuesday, April 8, 2025 Time: 9:30 am ET An audio webcast of the discussion will be available online at the OrthoPediatrics' investor relations website, Additionally, a replay will be available after the event. About OrthoPediatrics in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 75 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics' global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit Investor ContactPhilip Trip Taylor Gilmartin Groupphilip@
Yahoo
24-03-2025
- Business
- Yahoo
OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana
WARSAW, Ind., March 24, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ('OrthoPediatrics' or the 'Company') (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it was selected as one of the 2025 Best Places to Work in Indiana. This is the 9th time the Company has been recognized by the annual program created by the Indiana Chamber of Commerce. OrthoPediatrics President & CEO David Bailey commented, 'I'm so proud of our organization for being named one of the 'Best Places to Work' in Indiana for a 9th time. Our leadership team is committed to fostering an engaging and inclusive culture, and meaningful career experiences for all our associates. We are always investing in our people and looking for new and attractive ways to build on what we have created at OrthoPediatrics. It's an honor to know our colleagues feel proud to work for our company and advance our cause of helping KIDS.' The list features honorees from all corners of the state and more than 20 industries. In this 20th edition of the Indiana Chamber of Commerce initiative, a total of 150 companies made the cut. 'We all recognize that currently there is intense competition for talent. This program is a great way for organizations to take the temperature of their culture and how it's resonating with today's workers,' says Indiana Chamber President and CEO Vanessa Green Sinders. 'Companies on the right cultural track also are much more likely to be effective across the board and have increased productivity and overall success. We salute each of this year's winners for their commitment to displaying best practices in their workplaces, which are enabling them to attract and retain employees.' This statewide survey and awards program is designed to identify, recognize, and honor the participating employers in Indiana with the leading workplace cultures. The final rankings will be announced at an awards ceremony on Wednesday, April 30th, 2025, and then published in the Indiana Chamber's BizVoice® magazine after the event. For more information on the Best Places to Work in Indiana program, visit: About OrthoPediatrics in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 75 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics' global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit Investor ContactPhilip Trip TaylorGilmartin Groupphilip@ in to access your portfolio
